![Madhav Vasanthavada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 2 Mio $ am 31.05.2026
Madhav Vasanthavada is currently Chief Commercial Officer at Abeona Therapeutics, Inc. since 2023.
Education history includes a doctorate from the University of Rhode Island, an undergraduate degree from Osmania University, and an MBA from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 303’451 ( 0.53% ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osmania University
 Osmania University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
